SpliceCoreEnvisagenics
|
||||||
Related Products
|
||||||
About
What you get with Pulse Physical kiosks installed in your facility. We ship you a physical kiosk that is mounted within your building, providing your clients a quick, consistent way to leave feedback. No more dedicating resources to interviews, paper surveys, and spreadsheets. Online surveys available as well. Want to reach even more people, no problem. The Pulse survey can be sent out digitally, allowing you to reach clients through email and outreach groups. Use the data dashboard to see trends. Each survey is automatically consolidated into a data dashboard, which lets you filter and splice the data any way you see fit. You can see trends and anomalies in real time, allowing you to react and respond in a timely manner. Share your data. Sharing your data is a simple as clicking a button. You can print, download, and send, helping you get the data to who needs to see it quickly. Weekly Emails to key stakeholders.
|
About
Using RNA sequencing (RNA-seq) data and Artificial Intelligence are both a necessity and an opportunity to develop therapeutics that target splicing errors. The use of machine learning enables us to discover new splicing errors and quickly design therapeutic compounds to correct them. SpliceCore is our dedicated AI platform for RNA therapeutics discovery. We developed this technology platform specifically for the analysis of RNA sequencing data. It can identify, test and validate hypothetical drug targets faster than traditional methods. At the heart of SpliceCore is our proprietary database of more than 5 million potential RNA splicing errors. It is the largest database of splicing errors in the world and it is used to test every RNA sequencing dataset that is input for analysis. Scalable cloud computing enables us to process massive amounts of RNA sequencing data efficiently, at higher speed and lower cost, exponentially accelerating therapeutic innovation.
|
|||||
Platforms Supported
Windows
Not Supported
Mac
Not Supported
Linux
Not Supported
Cloud
Supported
On-Premises
Not Supported
iPhone
Not Supported
iPad
Not Supported
Android
Not Supported
Chromebook
Not Supported
|
Platforms Supported
Windows
Not Supported
Mac
Not Supported
Linux
Not Supported
Cloud
Supported
On-Premises
Not Supported
iPhone
Not Supported
iPad
Not Supported
Android
Not Supported
Chromebook
Not Supported
|
|||||
Audience
For behavior health organizations, community servces and other institutions looking for an app that provides client feedback
|
Audience
Labs seeking an AI platform to generate a volume of insights comparable to years of traditional drug target discovery
|
|||||
Support
Phone Support
Supported
24/7 Live Support
Not Supported
Online
Supported
|
Support
Phone Support
Supported
24/7 Live Support
Not Supported
Online
Supported
|
|||||
API
Offers API
Not Supported
|
API
Offers API
Not Supported
|
|||||
Screenshots and Videos |
Screenshots and Videos |
|||||
Pricing
$250 per month
Free Version
Not Supported
Free Trial
Not Supported
|
Pricing
No information available.
Free Version
Not Supported
Free Trial
Not Supported
|
|||||
Reviews/
|
Reviews/
|
|||||
Training
Documentation
Supported
Webinars
Not Supported
Live Online
Supported
In Person
Not Supported
|
Training
Documentation
Supported
Webinars
Not Supported
Live Online
Not Supported
In Person
Supported
|
|||||
Company InformationPulse For Good
Founded: 2017
United States
www.pulseforgood.com
|
Company InformationEnvisagenics
Founded: 2014
United States
www.envisagenics.com/platform/
|
|||||
Alternatives |
Alternatives |
|||||
|
|
||||||
|
|
|
|||||
|
|
||||||
Categories |
Categories |
|||||
Kiosk Features
Activity Reservations
Not Supported
Digital Signature
Not Supported
License Management
Not Supported
Onsite Printing
Not Supported
Remote Access
Supported
Secure Browsing
Supported
Ticket / Order Fulfillment
Not Supported
Touch Screen
Supported
Usage Reporting
Supported
Virtual Keyboard
Supported
Wireless Internet Access
Supported
|
||||||
Integrations
No info available.
|
Integrations
No info available.
|
|||||
|
|
|